Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Class A and Class B Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023   263,741,000        
Beginning balance at Jan. 31, 2023 $ 549,332 $ 9 $ 1,074,149 $ (23,831) $ (4,384) $ (496,611)
Beginning balance (in shares) at Jan. 31, 2023       14,131,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 43,310   43,310      
Exercise of stock options and vesting of restricted stock units (in shares)   8,305,000        
Exercise of stock options and vesting of restricted stock units 32,331   32,331      
Issuance of common shares upon ESPP purchases (in shares)   528,000        
Issuance of common shares upon ESPP purchases 3,970   3,970      
Other adjustment 0 $ (1) 1      
Other comprehensive income (loss) (999)       (999)  
Net income 30,260         30,260
Ending balance (in shares) at Oct. 31, 2023   272,574,000        
Ending balance at Oct. 31, 2023 658,204 $ 8 1,153,761 $ (23,831) (5,383) (466,351)
Ending balance (in shares) at Oct. 31, 2023       14,131,000    
Beginning balance (in shares) at Jul. 31, 2023   270,318,000        
Beginning balance at Jul. 31, 2023 617,286 $ 8 1,128,689 $ (23,831) (4,262) (483,318)
Beginning balance (in shares) at Jul. 31, 2023       14,131,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 14,091   14,091      
Exercise of stock options and vesting of restricted stock units (in shares)   2,256,000        
Exercise of stock options and vesting of restricted stock units 10,981   10,981      
Other comprehensive income (loss) (1,121)       (1,121)  
Net income 16,967         16,967
Ending balance (in shares) at Oct. 31, 2023   272,574,000        
Ending balance at Oct. 31, 2023 658,204 $ 8 1,153,761 $ (23,831) (5,383) (466,351)
Ending balance (in shares) at Oct. 31, 2023       14,131,000    
Beginning balance (in shares) at Jan. 31, 2024   273,265,000        
Beginning balance at Jan. 31, 2024 $ 679,704 $ 8 1,182,150 $ (23,831) (3,836) (474,787)
Beginning balance (in shares) at Jan. 31, 2024 14,130,784     14,131,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards $ 45,252   45,252      
Exercise of stock options and vesting of restricted stock units (in shares)   6,039,000        
Exercise of stock options and vesting of restricted stock units 18,919   18,919      
Issuance of common shares upon ESPP purchases (in shares)   455,000        
Issuance of common shares upon ESPP purchases 3,403   3,403      
Common stock repurchased, including accrued excise tax (in shares)   (25,460,000)        
Common stock repurchased, including accrued excise tax (272,989)         (272,989)
Other comprehensive income (loss) (195)       (195)  
Net income 22,930         22,930
Ending balance (in shares) at Oct. 31, 2024   254,299,000        
Ending balance at Oct. 31, 2024 $ 497,024 $ 8 1,249,724 $ (23,831) (4,031) (724,846)
Ending balance (in shares) at Oct. 31, 2024 14,130,784     14,131,000    
Beginning balance (in shares) at Jul. 31, 2024   253,366,000        
Beginning balance at Jul. 31, 2024 $ 468,967 $ 8 1,232,417 $ (23,831) (4,251) (735,376)
Beginning balance (in shares) at Jul. 31, 2024       14,131,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 15,623   15,623      
Exercise of stock options and vesting of restricted stock units (in shares)   933,000        
Exercise of stock options and vesting of restricted stock units 1,684   1,684      
Common stock repurchased, including accrued excise tax (in shares)   0        
Common stock repurchased, including accrued excise tax (75)         (75)
Other comprehensive income (loss) 220       220  
Net income 10,455         10,455
Ending balance (in shares) at Oct. 31, 2024   254,299,000        
Ending balance at Oct. 31, 2024 $ 497,024 $ 8 $ 1,249,724 $ (23,831) $ (4,031) $ (724,846)
Ending balance (in shares) at Oct. 31, 2024 14,130,784     14,131,000